| Controls |  | PCOS |  |
---|---|---|---|---|
RR (n = 335) | RH + HH (n = 151 + 15) | RR (n = 357) | RH + HH (n = 186 + 22) | |
Age (yr) | 28.10 ± 4.23 | 27.58 ± 4.12 | 24.98 ± 3.29 | 24.20 ± 3.81a |
BMI (kg/m2) | 21.14 ± 3.05 | 20.92 ± 2.53 | 23.09 ± 4.33 | 23.07 ± 4.10 |
Oxidative stress parameters | ||||
 TOS (nmol H2O2 Equiv./mL) | 11.27 ± 5.49 | 10.99 ± 4.92 | 15.42 ± 11.83 | 14.17 ± 8.88 |
 T-AOC (U/ml/min) | 14.38 ± 2.58 | 14.85 ± 2.84 | 15.84 ± 3.21 | 15.80 ± 2.83 |
 OSI | 0.81 ± 0.42 | 0.76 ± 0.37 | 1.02 ± 0.84 | 0.95 ± 0.72 |
 MDA (nmol/ml) | 3.67 ± 1.10 | 3.61 ± 1.04 | 4.31 ± 1.25 | 4.42 ± 1.14 |
PAF-AH activities and frequencies of PAF-AH G449T genotype* | ||||
 Plasma PAF-AH (nmol/min/ml) | 48.02 ± 11.14 | 48.90 ± 10.26 | 46.30 ± 13.32 | 49.37 ± 12.08a |
 H-PAF-AH (nmol/min/ml) | 5.04 ± 1.41 | 5.25 ± 1.59 | 4.51 ± 1.75 | 4.92 ± 2.14 |
 ApoB-PAF-AH (nmol/min/ml) | 42.98 ± 10.31 | 43.64 ± 9.37 | 41.79 ± 12.23 | 44.45 ± 11.14a |
 ApoB-PAF-AH/H-PAF-AH | 8.94 ± 2.60 | 8.77 ± 2.25 | 10.15 ± 4.37 | 9.85 ± 2.95 |
  PAF-AH G449T, n (%) | ||||
   GG | 158 (90.8%) | 97 (96.0%) | 150 (84.7%) | 93 (89.4%) |
   GT + TT | 16 + 0 (9.2%) | 4 + 0 (4.0%) | 23 + 4 (15.3%) | 11 + 0 (10.6%) |